Next Phase Newsletter

By Momo Yamamoto, Investor Research Analyst, LSN

LSN’s RESI Conference is coming to Barcelona, Spain for the first time on June 17th at The Hilton Diagonal Mar. We are excited to announce the Digital Health Investor Panel. LSN has brought together global investors of varied backgrounds to discuss recent trends, common mistakes, advice, and more, with a focus to push digital health innovations forward. Look below for our Digital Health panelists.

RESI Europe Digital Health Panel Speakers
Moderator
David Cole Venture Partner Springhood Ventures	Christian Bjelland Managing Director, Capital Network & Global Development ​​​​​​Redesign Healt	Jordi Ferrer Healthcare Investment Director ​​​​​​Ship2B Ventures
Tom Gibbs Director Debiopharm Innovation Fun	Ignasi Heras General Partner CRB Inverbio	Carsten Laue Managing Partner M2Car

The investor panels are a hallmark of the RESI Conference series where attendees can look forward to a comprehensive array of panel discussions. These panels will delve into a wide range of topics, from specific investor types providing a stimulating environment for startups and investors to explore potential funding opportunities. Each panel will be moderated by industry experts with deep domain knowledge, offering meaningful insights and fostering engaging discussions. Through this multifaceted approach, LSN strives to create a dynamic platform that facilitates networking, knowledge sharing, and the exploration of potential partnerships between startups and investors.

By Cameron Hurlburt, Director of Business Development, LSN

Greg Mannix VP of European Sales at Life Science Nation is also CEO of Novaurum Biosciences and has attended 15 life science partnering conferences in the last two years as a startup CEO. After this extensive experience, he shares his insights on whether these events are worth the investment and what constitutes a good return on investment (ROI) in terms of outcomes and the number of investor meetings secured. Attending partnering conferences can be a significant investment for life science companies, especially startups and early-stage firms. Mannix emphasizes the importance of carefully evaluating the potential ROI before committing resources.

A successful conference should yield tangible outcomes, such as securing funding, establishing strategic partnerships, or gaining valuable industry insights. Mannix suggests that a good ROI can be measured by the number of quality investor meetings scheduled during the event. “For a conference to be considered successful, I aim to secure at least 10-15 meetings with potential investors or partners that align with our company’s goals and stage of development,” Mannix explains. “These meetings should lead to meaningful discussions and potential collaborations or investment opportunities.”

To maximize the value of partnering events, Mannix recommends a strategic approach. Thorough preparation, targeted networking, and effective follow-up are crucial. “It’s essential to research the attending investors and companies beforehand and strategically request meetings with those that are the best fit,” Mannix advises. “During the event, actively participate in panel discussions, workshops, and networking sessions to gain industry insights and make valuable connections.” Mannix also emphasizes the importance of prompt and professional follow-up after the conference. “Timely and personalized communication with the contacts made during the event can significantly increase the chances of securing partnerships or investments,” he adds.

RESI Europe is taking place in Barcelona on June 17 (in-person) and June 18-19 (virtual). This conference aims to connect startups and early-stage investors, offering a platform for fundraising and partnership opportunities. With a 1:1 ratio of investors to companies and over 250 life science investors in attendance, RESI Europe promises to maximize the number of meetings and potential collaborations. Partnering has opened, and you can register today to secure meeting slots while they are still available.

While life science partnering conferences require an investment, they can provide substantial returns in terms of funding, partnerships, and industry insights when approached strategically. By carefully evaluating the potential ROI, preparing thoroughly, and actively engaging in networking and follow-up, companies can maximize the value of these events and propel their growth in the life science industry.

By Karen Deyo, VP of Product, Israel BD, LSN

Exciting news! The partnering platform for RESI Europe is launching on Monday, May 27. This unique platform allows companies and investors to request meetings based on their fit in technology and stage of development.

Attend In-Person or Virtually

Whether you plan to attend in person in Barcelona on Monday, June 17 or participate virtually on June 18-19, you can take advantage of this powerful partnering tool.

Targeted Meeting Requests

Companies attending RESI can review attending investors’ interests with pre-populated profiles from LSN’s Investor and Licensing Partner Database. This allows you to make targeted meeting requests, maximizing your chances of successful partnerships.

Strategies for Successful Partnering

To help you make the most of this opportunity, LSN recently hosted a webinar on strategies for successful partnering. Check out the recording here to learn how to improve your partnering game.

Upcoming Webinars

We’ll also be holding webinars on how to navigate the RESI partnering platform and use it to your best advantage after the partnering launch. Life Science Nation will host Partnering Tutorials on May 30 and June 13, 10 AM ET

• May 30, 2024 10:00 AM ET | Partnering Tutorial – Sign Up

• June 13, 2024 10:00 AM ET | Partnering Tutorial – Sign Up

Register for RESI Europe Now

Haven’t registered yet? Don’t miss out on this incredible opportunity! Register here to join us at RESI Europe.

By Faith Patenaude, Investor Research Analyst, LSN

The benefit of attending RESI Europe is not only due to the partnering and networking, but also the chance to learn from active investors on a variety of panel topics featured throughout the conference. Taking place in person June 17th and virtually June 18th – 19th, RESI Europe will feature a dynamic range of panels covering topics such as Oncology Innovation, Early-Stage Therapeutics, Cross Boarder Investments, and more!

We are excited to present our Seed Funds panel, taking place at 9:00AM June 17th, featuring 6 accomplished and seasoned investors. These experts, all from firms specializing in early-stage investments, will share their knowledge on key topics such as the level of proof-of-concept validation required for seed funding and the significant roles investors play in the early stages of companies. Additionally, they will discuss strategies on how to balance the high risks of early investments with the potential for increased returns. The panel will feature the below investors:

RESI Europe Seed Fund Panel Speakers
Farzad Abdi-Dezfuli Partner Sarsia	Jorge Blasco Venture Partner (Spain) Lumo Labs	Emma Gasol Investment Director AdBio partners
Soyoung Park Venture Partner (US & Europe) VU Venture Partners	Sara Secall Partner Inveready Asset Management	Jaromir Zahrádka CEO & Managing Partner, i&i Biotech Fund i&i Bio

By attending RESI Europe, you will have the opportunity to not only foster meaningful connections but gain valuable knowledge to support your fundraising efforts.

Don’t miss out on this incredible opportunity to learn from top investors and network with industry leaders. Join us in person on June 17th or virtually on June 18th and 19th. We look forward to seeing you at what promises to be another exceptional conference.

By Momo Yamamoto, Investor Research Analyst, LSN

Epidarex Capital, a transatlantic venture capital firm, provides valuable insights on what early-stage companies need to secure financing. In a concise video, Sinclair Dunlop, Managing Partner at Epidarex Capital, explains the key factors investors consider when evaluating potential investments. Click here to view the video.

For entrepreneurs seeking funding opportunities, RESI Europe in Barcelona offers a prime platform to connect with over 250 investors and licensing partners focused on early stage companies raising seed, Series A, or Series B financing. The conference features insightful investor panels where early-stage entrepreneurs can gain direct insights from active investors in their industry.

Dunlop emphasizes the importance of proactively bridging the early-stage funding gap, stating, ” In terms of attraction, in terms of milestones that have been hit, as opposed to a company that is ready for much larger financing round, or a company that is just not ready for institutional money at this point. We would not be looking for them to have met any milestones, frankly, on the way in. Because, by definition, that is all ahead of us. But our North Star is fundamental novelty. It must be novel in a way that is obviously commercially relevant. “ This approach aligns with the RESI conference’s mission to facilitate conversations that spark early-stage deals across drugs, devices, diagnostics, and digital health.

By attending RESI Europe, entrepreneurs can leverage the opportunity to pitch their ideas, network with potential investors, and gain valuable knowledge from industry experts. The conference provides a unique platform for early-stage companies to secure the funding and partnerships necessary for success.

By Joey Wong, Senior Investor Research Analyst, Hong Kong BD, LSN

A team of investors specializing in funding early-stage life science companies revealed what it takes to get the capital to advance your company in a webinar hosted last week by Life Science Nation (LSN). The panel underscored that investors are actively seeking innovative life science startups, but have high bars for team, technology validation, market potential, and fit with their investment theses. Watch the recording of the investor panel.

Investor Speakers
Merom Klein Head, Keiretsu Leadership Forum Keiretsu Forum	Carsten Laue Managing Partner M2Care	Laia Pascual Investment Manager Ship2B Ventures	Sara Secall General Partner Inveready Asset Management
Moderator
Trevor Thompson Investment Banker Ionic Advisors

Merom Klein of the Keiretsu Leadership Forum, Carsten Laue of M2Care, Laia Pascual of Ship2B Ventures and Sara Secall of Inveready Asset Management talk about the trends they are seeing in the industry, the key attributes they look for in technologies and presentations, and what makes a company an ideal partner. Moderated by Trevor Thompson of Ionic Advisors, this insider perspective from investors themselves is invaluable for entrepreneurs as they refine their fundraising strategies. Click above to watch the recording of the investor panel now and register for RESI Europe to meet over 250 investors at RESI Europe in Barcelona June 17 and virtually June 18-19!

By Cameron Hurlburt, Director of Business Development, LSN

Don’t miss out on the early bird discount for RESI Europe! This premier partnering conference connects early-stage life science and healthcare startups with investors and strategic partners perfectly matched to their product and stage of development.

The event kicks off on June 17th with an in-person gathering at the Hilton Diagonal Mar hotel in Barcelona, followed by two days of virtual partnering on June 18-19. Register by tomorrow Friday, May 17th, to save €200 on your attendance.

A Unique Partnering Experience

The RESI conference series stands out with its match-based partnering platform that takes the guesswork out of networking. Attendees can filter and connect with others based on their specific fundraising needs.

To learn more about this powerful tool, check out the recorded webinar: The LSN Event Partnering Process.

Tailored for Early-Stage Fundraising

In addition to partnering, RESI Europe offers:

Expert Panel Discussions on topics crucial to the early-stage fundraising ecosystem.

Innovator’s Pitch Challenge (IPC) where fundraising executives can pitch directly to a panel of active, relevant investors. IPC applications are first-come-first-served, and the deadline has been extended to May 22nd.

Whether you are sourcing elite technology assets or seeking a strategic funding partner, RESI Europe is a one-stop shop to meet your needs. Don’t miss out – register by May 17th to take advantage of the early bird rates!